Literature DB >> 7596538

Improvement of visual field indices after surgical reduction of intraocular pressure.

S A Gandolfi1.   

Abstract

In a prospective case series (consecutive patients) of 30 eyes from 30 subjects with medically uncontrolled glaucoma being treated at a hospital-based, referral glaucoma service, we sought to ascertain if a surgically obtained reduction of intraocular pressure (IOP) in human glaucomatous eyes is paralleled by an improvement of the visual field. Uncomplicated limbus-based trabeculectomy was performed in 13 men and 17 women familiar with computerized perimetry testing, with a pupil diameter of at least 4 mm (measured at the Goldmann perimeter bowl), a best-corrected visual acuity of 20/20 in both eyes, and a Mean Sensitivity (MS) index greater than 10 dB. The main outcomes measured were: visual field data (Octopus, program G1) and IOP (mean of the two highest values during the diurnal curve) obtained 3 days before and 3 months after surgery in both the operated and the fellow eyes. In the operated eyes, an increase of MS (from 17.2 +/- 2.4 to 18.9 +/- 2.8, P < .000001, paired samples two-tailed t test) was observed. Meanwhile, the Corrected Loss Variance (CLV) remained substantially the same (46.8 +/- 12.2 before, vs 47.3 +/- 13.4 after; P = .87, paired samples two-tailed t test). The increase in MS was positively correlated with the amount of IOP reduction (linear regression: r = 0.901, P < .00001). No statistically significant change of either MS or CLV values occurred in the fellow eyes. The correlation between the amount of IOP reduction and the increased MS suggests that, in the short term, reducing the IOP may improve visual function to some extent. The apparent lack of correlation between the amount of IOP reduction and the CLV may indicate that the depth of the preexistent glaucomatous scotomas remains unchanged.

Entities:  

Mesh:

Year:  1995        PMID: 7596538

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  8 in total

1.  No changes in anatomical and functional glaucoma evaluation after trabeculectomy.

Authors:  Ivan Maynart Tavares; Luiz Alberto S Melo; João A Prata; Roberta Galhardo; Augusto Paranhos; Paulo Augusto A Mello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-01       Impact factor: 3.117

2.  Improved retinal function after trabeculectomy in glaucoma patients.

Authors:  Elisabeth Wittström; Patrik Schatz; Monica Lövestam-Adrian; Vesna Ponjavic; Anders Bergström; Sten Andréasson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-29       Impact factor: 3.117

3.  Effect of Trabeculectomy on OCT Measurements of the Optic Nerve Head Neuroretinal Rim Tissue.

Authors:  Facundo G Sanchez; David S Sanders; Jessica J Moon; Stuart K Gardiner; Juan Reynaud; Brad Fortune; Steven L Mansberger
Journal:  Ophthalmol Glaucoma       Date:  2019-10-04

Review 4.  Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications.

Authors:  Amir H Kashani; Chieh-Li Chen; Jin K Gahm; Fang Zheng; Grace M Richter; Philip J Rosenfeld; Yonggang Shi; Ruikang K Wang
Journal:  Prog Retin Eye Res       Date:  2017-07-29       Impact factor: 21.198

5.  Effect of trabeculectomy on retrobulbar circulation and visual field progression in patients with primary open-angle glaucoma.

Authors:  Yoshio Yamazaki; Fukuko Hayamizu
Journal:  Clin Ophthalmol       Date:  2012-09-21

6.  Lack of Visual Field Improvement After Initiation of Intraocular Pressure Reducing Treatment in the Early Manifest Glaucoma Trial.

Authors:  Boel Bengtsson; Anders Heijl
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-10-01       Impact factor: 4.799

7.  Blebs, Barriers, and Bagpipes: Why is It so Hard?

Authors:  Michael Coote
Journal:  J Curr Glaucoma Pract       Date:  2016-10-29

8.  Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma.

Authors:  Jessica Tang; Flora Hui; Xavier Hadoux; Bernardo Soares; Michael Jamieson; Peter van Wijngaarden; Michael Coote; Jonathan G Crowston
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.